Long term follow-up of refractory/relapsed hairy cell leukaemia patients treated with low-dose vemurafenib between 2013 and 2022 at the Department of Internal Medicine and Oncology, Semmelweis University.
Saved in:
| Title: | Long term follow-up of refractory/relapsed hairy cell leukaemia patients treated with low-dose vemurafenib between 2013 and 2022 at the Department of Internal Medicine and Oncology, Semmelweis University. |
|---|---|
| Authors: | Ferenczi K; Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary., Nagy ZF; Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary., Istenes I; Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary., Eid H; Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary., Bödör C; 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary., Timár B; 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary., Demeter J; Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary. |
| Source: | Pathology oncology research : POR [Pathol Oncol Res] 2023 Nov 08; Vol. 29, pp. 1611378. Date of Electronic Publication: 2023 Nov 08 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media S. A Country of Publication: Switzerland NLM ID: 9706087 Publication Model: eCollection Cited Medium: Internet ISSN: 1532-2807 (Electronic) Linking ISSN: 12194956 NLM ISO Abbreviation: Pathol Oncol Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1532-2807 |
|---|---|
| DOI: | 10.3389/pore.2023.1611378 |